 Fulgent Genetics, Inc. NASDAQ:FLGT Q2 2022 Results Earnings Conference Call August 4, 2022 4:30 PM ET Company Participants Nicole Borsje - Investor Relations, The Blueshirt Group Ming Hsieh - Chairman and Chief Executive Officer Brandon Perthuis - Chief Commercial Officer Lawrence Weiss - Chief Medical Officer Paul Kim - Chief Financial Officer Conference Call Participants David Westenberg - Piper Sandler Operator Good day and welcome to the Q2 2022 Fulgent Genetics Earnings Conference Call. As reminder, todays call is being recorded. 